# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA905249 | A | Cytotoxicity against E6SM cells assessed as alteration in cell morphology | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
2. | ALA905250 | F | Antiviral activity against HSV1 KOS in E6SM cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 1 | 10 | organism-based format | Scientific Literature | ||
3. | ALA905251 | F | Antiviral activity against HSV2 G in E6SM cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 2 | 10 | organism-based format | Scientific Literature | ||
4. | ALA905252 | F | Antiviral activity against Vaccinia virus in E6SM cells assessed as reduction of virus-induced cytopathogenicity | Vaccinia virus | 10 | organism-based format | Scientific Literature | ||
5. | ALA905253 | F | Antiviral activity against thymidine kinase-deficient HSV1 B2006 in E6SM cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 1 | 10 | organism-based format | Scientific Literature | ||
6. | ALA905254 | F | Antiviral activity against thymidine kinase deficient HSV1 VMW1837 in E6SM cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 1 | 10 | organism-based format | Scientific Literature | ||
7. | ALA905255 | F | Antiviral activity against HCMV AD169 in HEL cells assessed as reduction of virus plaque formation | Human betaherpesvirus 5 | 8 | organism-based format | Scientific Literature | ||
8. | ALA905256 | F | Antiviral activity against HCMV Davis in HEL cells assessed as reduction of virus plaque formation | Human betaherpesvirus 5 | 8 | organism-based format | Scientific Literature | ||
9. | ALA905257 | A | Cytotoxicity against HEL cells assessed as alteration in cell morphology | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
10. | ALA905258 | A | Cytotoxicity against HEL cells | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
11. | ALA905259 | F | Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation | Human alphaherpesvirus 3 | 6 | organism-based format | Scientific Literature | ||
12. | ALA905260 | F | Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation | Human alphaherpesvirus 3 | 6 | organism-based format | Scientific Literature | ||
13. | ALA905261 | F | Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation | Human alphaherpesvirus 3 | 6 | organism-based format | Scientific Literature | ||
14. | ALA905262 | F | Antiviral activity against thymidine kinase deficient VZV YS in HEL cells assessed as reduction of virus plaque formation | Human alphaherpesvirus 3 | 4 | organism-based format | Scientific Literature | ||
15. | ALA905268 | F | Inhibition of proliferation of mouse FM3A/O cells | Mus musculus | 6 | cell-based format | Scientific Literature | ||
16. | ALA885977 | F | Inhibition of proliferation of thymidine kinase deficient mouse FM3A cells | Mus musculus | 6 | cell-based format | Scientific Literature | ||
17. | ALA885978 | F | Inhibition of proliferation of thymidine kinase deficient mouse FM3A cells expressing HSV1 thymidine kinase | Mus musculus | 6 | cell-based format | Scientific Literature | ||
18. | ALA885979 | F | Inhibition of proliferation of thymidine kinase deficient mouse FM3A cells expressing HSV2 thymidine kinase | Mus musculus | 6 | cell-based format | Scientific Literature | ||
19. | ALA885980 | F | Inhibition of proliferation of thymidine kinase deficient OST cells | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
20. | ALA885981 | F | Inhibition of proliferation of VZV thymidine kinase expressing OSTtk-/VZVtk+ -a cells | Homo sapiens | 8 | assay format | Scientific Literature |